Aurobindo Pharma Ltd Nine Monthly Results

Gross Sales

22,997.01

21,212.58

18,238.46

17,571.21

18,566.27

Excise Duty

0

0

0

0

0

Net Sales

22,997.01

21,212.58

18,238.46

17,571.21

18,566.27

Other Operating Income

344.6

209.14

143.96

74.91

206.86

Other Income

514.72

436.04

178.33

306.26

3,116.63

Total Income

23,856.33

21,857.76

18,560.75

17,952.38

21,889.76

Total Expenditure

18,577.92

17,340.06

15,694.42

14,260.89

14,761.38

PBIDT

5,278.41

4,517.7

2,866.33

3,691.49

7,128.38

Interest

342.22

200.28

84.88

39.43

56.27

PBDT

4,936.19

4,317.42

2,781.45

3,652.06

7,072.11

Depreciation

1,204.99

1,167.33

899.01

872.95

789.38

Minority Interest Before NP

0

0

0

0

0

Tax

1,269.47

1,206.9

491.09

652.3

1,870.45

Deferred Tax

-119.01

-318.43

-30.39

55.84

-126.05

Reported Profit After Tax

2,580.74

2,261.62

1,421.74

2,070.97

4,538.33

Minority Interest After NP

-1.67

-2.6

0.51

-0.72

-0.62

Net Profit after Minority Interest

2,582.41

2,264.22

1,421.23

2,071.69

4,538.95

Extra-ordinary Items

0

-43.03

0

25.93

1,976.16

Adjusted Profit After Extra-ordinary item

2,582.41

2,307.25

1,421.23

2,045.76

2,562.79

EPS (Unit Curr.)

44.25

38.6

24.26

35.36

77.46

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

150

300

450

400

Equity

58.08

58.59

58.59

58.59

58.59

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

22.95

21.29

15.71

21

38.39

PBDTM(%)

21.46

20.35

15.25

20.78

38.09

PATM(%)

11.22

10.66

7.79

11.78

24.44